New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2013
07:45 EDTPRTAProthena price target raised to $38 from $30 at RBC Capital
RBC Capital increased its price target on Prothena (PRTA) after the company announced a worldwide partnership with Roche (RHHBY) on PRX-002 for Parkinson's disease. The firm thinks the deal creates potential value on an asset that previously was given little credit, while validating Prothena's expertise. The firm keeps an Outperform rating on the shares.
News For PRTA From The Last 14 Days
Check below for free stories on PRTA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
12:00 EDTPRTAProthena rises 17.4%
Subscribe for More Information
April 9, 2014
10:06 EDTPRTAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:08 EDTPRTAProthena initiated with a Buy at Citigroup
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use